{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:57:01Z","timestamp":1775933821025,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Italian Medicines Agency","doi-asserted-by":"publisher","award":["RC 2015"],"award-info":[{"award-number":["RC 2015"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"AIFA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.05.041","type":"journal-article","created":{"date-parts":[[2015,5,31]],"date-time":"2015-05-31T12:04:15Z","timestamp":1433073855000},"page":"3444-3449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: A systematic review"],"prefix":"10.1016","volume":"33","author":[{"given":"Paolo","family":"Pellegrino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Radice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.041_bib0295","first-page":"1","article-title":"Review of gardasil","author":"Harper","year":"2010","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0300","first-page":"7","article-title":"Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies","volume":"10","author":"Harper","year":"2010","journal-title":"Discov Med"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0305","doi-asserted-by":"crossref","first-page":"457204","DOI":"10.5402\/2011\/457204","article-title":"Next generation cancer protection: the bivalent HPV vaccine for females","volume":"2011","author":"Harper","year":"2011","journal-title":"ISRN Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: human papillomavirus and cervical cancer\u2014burden and assessment of causality","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0315","first-page":"2164","article-title":"HPV vaccine against HPV infection and disease in males","volume":"364","author":"Harper","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0320","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7774\/cevr.2014.3.2.168","article-title":"Current status of human papillomavirus vaccines","volume":"3","author":"Kim","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0325","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0929-6646(10)60081-2","article-title":"Current status of human papillomavirus vaccines","volume":"109","author":"Ma","year":"2010","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0330","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2165\/10898580-000000000-00000","article-title":"Human papillomavirus vaccines: current status and future prospects","volume":"70","author":"Garland","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0335","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0340","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/art.30483","article-title":"High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort","volume":"63","author":"Dreyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0345","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","article-title":"Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: a meta-analysis of the literature","volume":"13","author":"Zard","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0350","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0961203311425517","article-title":"Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis","volume":"21","author":"Rojo-Contreras","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0355","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1586\/14760584.2014.930346","article-title":"Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake?","volume":"13","author":"Feldman","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0360","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10067-010-1606-0","article-title":"Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review","volume":"30","author":"Santana","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0365","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","article-title":"Systemic lupus erythematosus and the risk of malignancy","volume":"10","author":"Cibere","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0370","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2013.07.007","article-title":"Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity","volume":"13","author":"Murdaca","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0375","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2008.07.007","article-title":"Vaccination and autoimmune rheumatic diseases","volume":"8","author":"Conti","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0380","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.3748\/wjg.v12.i38.6167","article-title":"Abnormalities of uterine cervix in women with inflammatory bowel disease","volume":"12","author":"Bhatia","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0385","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal Pap smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0390","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/ibd.20959","article-title":"Lack of association between cervical dysplasia and IBD: a large case-control study","volume":"15","author":"Lees","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0395","article-title":"Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study","author":"Kim","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0400","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrrheum.2012.114","article-title":"Paediatric rheumatic disease: biologic therapy and risk of infection in children with JIA","volume":"8","author":"Horneff","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0405","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/art.34458","article-title":"Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment","volume":"64","author":"Beukelman","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0410","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis","volume":"11","author":"Lu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0420","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.26362","article-title":"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201325 years with and without serological evidence of previous exposure to HPV-16\/18","volume":"131","author":"Szarewski","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0425","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(09)61567-1","article-title":"Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years","volume":"374","author":"GlaxoSmithKline Vaccine HPVSG","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0430","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.autrev.2014.01.054","article-title":"On the relationship between human papilloma virus vaccine and autoimmune diseases","volume":"13","author":"Pellegrino","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0435","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/EDE.0000000000000033","article-title":"Human papillomavirus vaccine in patients with systemic lupus erythematosus","volume":"25","author":"Pellegrino","year":"2014","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0440","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10654-013-9830-y","article-title":"No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus","volume":"28","author":"Pellegrino","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0445","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/aji.12190","article-title":"On the association between human papillomavirus vaccine and primary ovarian failure","volume":"71","author":"Pellegrino","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0450","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/1352458513502114","article-title":"Can HPV immunisation cause ADEM? Two case reports and literature review","volume":"20","author":"Pellegrino","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0455","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0460","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-11-29","article-title":"Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years","volume":"11","author":"Soybilgic","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0465","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood-2013-04-494096","article-title":"The effect of rituximab on vaccine responses in patients with immune thrombocytopenia","volume":"122","author":"Nazi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0470","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1016\/j.vaccine.2014.06.068","article-title":"Efficacy of vaccination against influenza in patients with multiple sclerosis: the role of concomitant therapies","volume":"32","author":"Pellegrino","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0475","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3899\/jrheum.130246","article-title":"Immunogenicity of the bivalent human papillomavirus vaccine in adolescents with juvenile systemic lupus erythematosus or juvenile dermatomyositis","volume":"40","author":"Heijstek","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0480","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/MIB.0b013e318281341b","article-title":"Immunogenicity and tolerability to human papillomavirus-like particle vaccine in girls and young women with inflammatory bowel disease","volume":"19","author":"Jacobson","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0485","first-page":"1","article-title":"Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis","author":"Esposito","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0490","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/annrheumdis-2013-203429","article-title":"Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study","volume":"73","author":"Heijstek","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0495","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-206426","article-title":"Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis","author":"Akioka","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0500","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0505","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10067-013-2266-7","article-title":"Human papillomavirus vaccine and systemic lupus erythematosus","volume":"32","author":"Gatto","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0510","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/ibd.20944","article-title":"General health maintenance in IBD","volume":"15","author":"Moscandrew","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0515","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ibd.20731","article-title":"Influenza vaccinations: should they really be encouraged for IBD patients being treated with immunosuppressives?","volume":"15","author":"Fields","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0520","article-title":"The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems","author":"Pellegrino","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0525","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","article-title":"The spectrum of post-vaccination inflammatory CNS demyelinating syndromes","volume":"13","author":"Karussis","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0530","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2014.06.006","article-title":"Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model","author":"Agmon-Levin","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0540","article-title":"The first steps towards the era of personalised vaccinology: predicting adverse reactions","author":"Pellegrino","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0545","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)60920-X","article-title":"Efficacy, safety, and immunogenicity of the human papillomavirus 16\/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study","author":"Skinner","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0550","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)61230-7","article-title":"HPV vaccination: for women of all ages?","author":"Castle","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0555","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2012-202561","article-title":"Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study","volume":"73","author":"Stoof","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0560","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1471-2334-11-333","article-title":"The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali","volume":"11","author":"Veldhuijzen","year":"2011","journal-title":"Rwanda. BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0565","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/1471-2407-14-451","article-title":"Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia","volume":"14","author":"Camargo","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0570","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1479-828X.2010.01269.x","article-title":"HPV infection and cervical disease: a review","volume":"51","author":"Carter","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0575","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1071\/SH14015","article-title":"Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives","volume":"11","author":"Toft","year":"2014","journal-title":"Sex Health"},{"key":"10.1016\/j.vaccine.2015.05.041_bib0580","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T06:34:11Z","timestamp":1537598051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":58,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15006933"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}